Prime Medicine, Inc.
PRME · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $346,313 | $805,988 | $1,806,147 | $997,513 |
| - Cash | $182,476 | $41,574 | $187,620 | $185,420 |
| + Debt | $40,794 | $13,633 | $28,745 | $10,406 |
| Enterprise Value | $204,631 | $778,047 | $1,647,272 | $822,499 |
| Revenue | $2,983 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $2,983 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$196,339 | -$186,639 | -$114,320 | -$83,906 |
| % Margin | -6,581.9% | – | – | – |
| Net Income | -$195,882 | -$198,133 | -$121,821 | -$165,367 |
| % Margin | -6,566.6% | – | – | – |
| EPS Diluted | -1.652 | -2.178 | -1.461 | -1.923 |
| % Growth | 24.2% | -49.1% | 24% | – |
| Operating Cash Flow | -$122,865 | -$165,412 | -$131,827 | -$34,082 |
| Capital Expenditures | -$7,294 | -$8,724 | -$16,095 | -$4,150 |
| Free Cash Flow | -$130,159 | -$174,136 | -$147,922 | -$38,232 |